On paper great. - Avis employé Bioinformatics Scientist NeoGenomics

3,0
5 sept. 2024
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Lots of benefits like pension, health insurance, life insurance, enhanced maternity leave, and decent pay.

Inconvénients

R&D department focus is messy, and always changing, reducing the sense of stability and making it difficult to plan a career growth.

Découvrez plus d’avis sur NeoGenomics

5,0
11 mars 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Growing business opportunities for many job seekers

Inconvénients

Ever changing approach on direction on projects

2,0
2 mars 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

The workforce wants to do the right thing. We take pride in knowing our services impact people's lives everyday.

Inconvénients

Constant turnover, lack of communication throughout - top to bottom. Leadership is struggling and not performing, Most of their attempts to improve growth have lost money. This is factual, not to be mistaken with statements from a disgruntled employee. An article published after the recent earnings release emphasized NEO's 5-year Return on Invested Capital is -10.5%, meaning management doesn't spend our capital wisely. This, along with heavy debt, minimal cash and returns at the bottom of the healthcare sector, should make you pause and do more research before jumping on board.

5
Voir les avis par: Utile|Évaluation|Date|Tout